Home
Conditions
Hematologic Neoplasms

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,027 public trials 268 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Completed

Phase I Study of mPEG-R-Crisantaspase Given IV

NCT01551524

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +10 more
Locations: Centre Henri Becquerel Rouen, Cedex, France

Hôpital Henri Mondor Créteil, France

Hôpitaux du CHU de Nantes Nantes, France

Hospices Civils de Lyon Pierre-Bénite, France

View Trial Details

Completed

Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant

NCT01244906

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +29 more
Locations: Northside Hospital Atlanta, Georgia, United States

View Trial Details

Completed

ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.

NCT00440479

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Bergen op Zoom, Netherlands

Breda, Netherlands

Ede Gld, Netherlands

Flushing, Netherlands

View Trial Details

Completed

Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies

NCT00673114

Conditions: Anemia, Anemia, Aplastic, Aplastic Anemia, +10 more
Locations: Duke University Medical Center Pediatric Blood and Marrow Transplant Durham, North Carolina, United States

View Trial Details

Completed

Scripps Tumorgraft Study

NCT01726699

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +3 more
Locations: Scripps Translational Science Institute La Jolla, California, United States

View Trial Details

Completed

Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)

NCT01344707

Conditions: Advanced Hematologic Malignancies, Blood Protein Disorders, Bone Marrow Diseases, +30 more
Locations: Universiätsklinikum Köln Cologne, Germany

Robert-Bosch-Krankenhaus Stuttgart, Germany

Universitätsklinikum Würzburg Würzburg, Germany

View Trial Details

Completed

Clofarabine in Chronic Lymphocytic Leukemia

NCT00028418

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations: University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD

NCT00185796

Conditions: Blood Cancer, Bone Marrow Diseases, Hematologic Diseases, +6 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area

NCT02372357

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancy, +3 more
Locations: Catholic University Leuven - Department of Pharmaceutical and Pharmacological Sciences Leuven, Vlaams-Brabant, Belgium

Institutul Clinic Fundeni Bucharest, Sector 2, Romania

View Trial Details

Completed

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

NCT00809276

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +34 more
Locations: The Sydney Kimmel Comprehensive Cancer center Baltimore, Maryland, United States

Marcos deLima, MD Houston, Texas, United States

Paul V. O'Donnell, M.D., Ph.D. Seattle, Washington, United States

View Trial Details

Hematologic Neoplasms

Hematologic Neoplasms trial results

Related conditions